Generated by AI
Quoin Pharmaceuticals, Ltd. American Depositary Shares are a depositary security representing ownership in Quoin Pharmaceuticals Ltd., a clinical-stage specialty pharmaceutical company focused on developing therapeutic products for rare and orphan diseases. The company’s current programs center on dermatology and other uncommon conditions, including treatments under study for Netherton syndrome, recessive dystrophic epidermolysis bullosa, peeling skin syndrome, SAM syndrome, ichthyosis, and scleroderma. Quoin Pharmaceuticals operates in the biotechnology and specialty drug segment, where its work is aimed at advancing targeted therapies for patient populations with limited treatment options. Its American Depositary Shares provide investors with access to the company’s equity through a U.S.-traded instrument, while the underlying business remains centered on research, development, and potential commercialization of orphan-disease therapies.
Website42127 Pleasant Forest Court
Ashburn, VA, 20148-7349
United States
The latest articles about QNRX.
Summary of Aug 31's posts. Generated by AI.
Summary of Aug 28's posts. Generated by AI.
Summary of Aug 31's posts. Generated by AI.
Investors talking about QNRX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.